Decentralized Trial Technology Insights

1. Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them 10/28/2025

   Explore some of the common pitfalls witnessed in healthcare environments, as well as guidance for implementing a penetration testing program. 

2. Penetration Testing In Healthcare: HIPAA And GDPR Requirements 10/27/2025

   Learn about penetration testing requirements in the healthcare environment, including clinical research, according to HIPAA and GDPR. 

3. RFK Jr. Wants Every American Wearing A Wearable. How Can Pharma Build A Business Around It? 9/16/2025

   The timing is now for pharma to be all-in on using wearables as their new business strategy, says Digital Medicine Society (DiMe) Director of Partnerships Smit Patel, PharmD.

4. Ask An Expert Before Shredding Your Mobile Device CAPEX 8/14/2025

   Tasked with buying your company's mobile devices and not sure where to start? Discover the questions you should ask and the information you need to know before consulting an expert.

5. Can Digital Endpoints Really Accelerate Clinical Trials? 8/8/2025

   Digital biomarkers are quickly and quietly becoming the digital revolution needed to make clinical trials quicker and more data rich. Discover how they are being used in clinical trials right now.

6. Tufts & PACT Release New DCT Analysis 7/7/2025

   We take a closer look at some of the key stats in a new DCT report from the Partnership for Advancing Clinical Trials (PACT), a consortium hosted and facilitated by the Tufts Center for the Study of Drug Development (CSDD).

7. Not What I Expected From A Vendor Conference 9/12/2024

   Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites. 

8. Can DCTs Be Both Patient Centric And Financially Efficient For Sites? 9/22/2023

   While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.

9. Advancing Rare Disease Research With Patient Registries 6/16/2023

   In this Q&A, “Rare dad” Harsha Rajasimha, Ph.D. of IndoUSrare discusses the current state of rare disease research and explains how patient registries can help propel drug development for rare disease therapies. 

10. Clinical Trial Diversity, Flexibility Championed By The Food And Drug Omnibus Reform Act 5/23/2023

    The Food and Drug Omnibus Reform Act, signed into law by President Biden on Dec. 29, 2022, includes provisions intended to modernize clinical trials and are broadly divided into two categories: encouraging the enrollment of diverse populations and facilitating novel clinical trial designs.